Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:57:22.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for amivantamab in recurrent or metastatic adenoid cystic carcinoma is displayed, with trial design, eligibility requirements, outcome measures, participating locations, and study documents and results.
    Difference
    53%
    Check dated 2026-11-11T01:12:32.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.8.0 instead of v3.7.2. The study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:23:48.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the site navigation, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:59:52.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T22:59:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error with a minimal HTML frame and a Home link, indicating restricted access rather than updated study information.
    Difference
    0.5%
    Check dated 2026-09-29T23:14:20.000Z thumbnail image

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.